Amedeo Smart

Free Medical Literature Service


 

Amedeo

Anemia

  Free Subscription

Articles published in
Ann Hematol
    August 2022
  1. BEYAR-KATZ O, Perry C, On YB, Amit O, et al
    Thrombopoietin receptor agonist for treating bone marrow aplasia following anti-CD19 CAR-T cells-single-center experience.
    Ann Hematol. 2022;101:1769-1776.
    >> Share

  2. ZHOU F, Zhang F, Zhang L, Wu Q, et al
    A multicentre trial of intensive immunosuppressive therapy combined with umbilical cord blood for the treatment of severe aplastic anaemia.
    Ann Hematol. 2022;101:1785-1794.
    >> Share

  3. PIRIYAKHUNTORN P, Tantiworawit A, Kasitanon N, Louthrenoo W, et al
    Prevalence and characteristics of inflammatory rheumatic diseases in patients with thalassemia.
    Ann Hematol. 2022;101:1667-1675.
    >> Share

  4. JAFRI F, Seong G, Jang T, Cimpeanu E, et al
    L-glutamine for sickle cell disease: more than reducing redox.
    Ann Hematol. 2022;101:1645-1654.
    >> Share

  5. LOBITZ S, Frommel C, Brose A, Blankenstein O, et al
    Simultaneous newborn screening for sickle cell disease, biotinidase deficiency, and hereditary tyrosinemia type 1 with an optimized tandem mass spectrometry protocol.
    Ann Hematol. 2022;101:1859-1860.
    >> Share

    July 2022
  6. AL-KURAISHY HM, Al-Gareeb AI, Kaushik A, Kujawska M, et al
    Hemolytic anemia in COVID-19.
    Ann Hematol. 2022 Jul 8. pii: 10.1007/s00277-022-04907.
    >> Share

  7. HAN B, Kim HJ, Yhim HY, Oh D, et al
    Sequential eradication of Helicobacter pylori as a treatment for immune thrombocytopenia in patients with moderate thrombocytopenia: a multicenter prospective randomized phase 3 study.
    Ann Hematol. 2022;101:1435-1445.
    >> Share

  8. JUNG EH, Park JH, Hwan Kim K, Kim JS, et al
    Characteristics of Sweet syndrome in patients with or without malignancy.
    Ann Hematol. 2022;101:1499-1508.
    >> Share

  9. ROPERO P, Gonzalez Fernandez FA, Nieto JM, Recasens V, et al
    Does size matter? Two new deletions in the HBB gene cause beta(0)-thalassemia.
    Ann Hematol. 2022;101:1465-1471.
    >> Share

  10. WU X, Cheng L, Liu X, Sun Y, et al
    Clinical characteristics and outcomes of 100 adult patients with pure red cell aplasia.
    Ann Hematol. 2022;101:1493-1498.
    >> Share

  11. PATSOURAKOS D, Aggeli C, Gatzoulis KA, Delicou S, et al
    Left atrial deformation indices in beta-thalassemia major patients.
    Ann Hematol. 2022;101:1473-1483.
    >> Share

  12. ADAM AS, Cotton F, Cantinieaux B, Benyaich S, et al
    Screening for hereditary spherocytosis in daily practice: what is the best algorithm using erythrocyte and reticulocyte parameters?
    Ann Hematol. 2022;101:1485-1491.
    >> Share

  13. COSTANTINI S, Meloni A, Spasiano A, Cinque P, et al
    The unexpected impact of cabozantinib on red blood cells consumption in patients with transfusion-dependent thalassemia.
    Ann Hematol. 2022;101:1621-1623.
    >> Share

    June 2022
  14. MA X, Zuo Y, Xu Z, Zhang Y, et al
    Comparable clinical outcomes of haploidentical hematopoietic stem cell transplantation in patients with hepatitis-associated aplastic anemia and non-hepatitis-associated aplastic anemia.
    Ann Hematol. 2022 Jun 23. pii: 10.1007/s00277-022-04885.
    >> Share

  15. HWANG YY, Chan TSY, Chan FHY, Lau CWP, et al
    Eltrombopag as frontline treatment of aplastic anaemia in routine practice: implications on cost and efficacy.
    Ann Hematol. 2022;101:1163-1172.
    >> Share

  16. ZHOU X, Jiang P, Gao L, Yang J, et al
    Immune reconstitution and survival of patients with parvovirus B19 related pure red cell aplasia after haplo-PBSCT.
    Ann Hematol. 2022;101:1333-1342.
    >> Share

  17. ESCRIBANO SERRAT S, Del Campo Balguerias G, Martinez Nieto J, Medina Salazar F, et al
    Pincered red cells in hereditary spherocytosis.
    Ann Hematol. 2022;101:1393-1394.
    >> Share

    May 2022
  18. PIRES DA SILVA BGP, Fonseca NP, Catto LFB, Pereira GC, et al
    The spectrum of paroxysmal nocturnal hemoglobinuria clinical presentation in a Brazilian single referral center.
    Ann Hematol. 2022;101:999-1007.
    >> Share

  19. POPLAWSKA M, Dutta D, Jayaram M, Chong NS, et al
    Genes modulating intestinal permeability and microbial community are dysregulated in sickle cell disease.
    Ann Hematol. 2022;101:1009-1013.
    >> Share

    April 2022
  20. KAYNAR LA, Gokcen S, Can F, Yegin ZA, et al
    Comparison of daily oral iron replacement therapy with every other day treatment in female reproductive age patients with iron-deficiency anemia.
    Ann Hematol. 2022 Apr 23. pii: 10.1007/s00277-022-04835.
    >> Share

  21. WERNER R, Lohr B, Lodemann P, Chemnitz JM, et al
    Autoimmune basal ganglia encephalitis with hemolytic anemia.
    Ann Hematol. 2022 Apr 21. pii: 10.1007/s00277-022-04848.
    >> Share

  22. PROCHASKA MT, Huisingh-Scheetz M, Meltzer D
    Sex differences in fatigue and symptoms of anemia in relation to hemoglobin level in hospitalized patients.
    Ann Hematol. 2022 Apr 11. pii: 10.1007/s00277-022-04830.
    >> Share

  23. LI S, Guo P, Mi L, Chai X, et al
    A novel SPTB mutation causes hereditary spherocytosis via loss-of-function of beta-spectrin.
    Ann Hematol. 2022;101:731-738.
    >> Share

    March 2022
  24. BAHATI YL, Delanghe J, Balaluka GB, Philippe J, et al
    Exploration of the relationship between anemia and iron and zinc deficiencies in children under 5 years of age living in the malaria endemic area of South Kivu/Democratic Republic of Congo.
    Ann Hematol. 2022 Mar 23. pii: 10.1007/s00277-022-04816.
    >> Share

  25. TOLU SS, Crouch A, Choi J, Gao Q, et al
    Hydroxyurea and fetal hemoglobin effect on leg ulcers in patients with sickle cell disease.
    Ann Hematol. 2022;101:541-548.
    >> Share

  26. LUFTINGER R, Zubarovskaya N, Galimard JE, Cseh A, et al
    Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia major.
    Ann Hematol. 2022;101:655-665.
    >> Share

  27. BAYRAKTAROGLU S, Karadas N, Onen S, Karapinar DY, et al
    Modern management of iron overload in thalassemia major patients guided by MRI techniques: real-world data from a long-term cohort study.
    Ann Hematol. 2022;101:521-529.
    >> Share

  28. SOULIERES D, Mercier-Ross J, Fradette C, Rozova A, et al
    The pharmacokinetic and safety profile of single-dose deferiprone in subjects with sickle cell disease.
    Ann Hematol. 2022;101:533-539.
    >> Share

  29. LI S, Chen K, Huang C, Zhang N, et al
    First report of successful treatment for hemoglobin Bristol-Alesha by hemopoietic stem cell transplantation.
    Ann Hematol. 2022;101:617-619.
    >> Share

  30. ROSETTI M, De la Salle B, Farneti G, Clementoni A, et al
    The added value of digital morphological analysis in the evaluation of peripheral blood films: the report of an UKNEQAS external quality assessment sample.
    Ann Hematol. 2022;101:729-730.
    >> Share

  31. FARFAN-QUIROGA G, Hermosilla-Fernandez MDM, Feliu-Sanchez J, Najera-Irazu MJ, et al
    A new case of Bicetre hemoglobin in an adult male: clinical observations over a period of four years.
    Ann Hematol. 2022;101:701-702.
    >> Share

    February 2022
  32. VIROT E, Thuret I, Jardel S, Herbrecht R, et al
    Pregnancy outcome in women with transfused beta-thalassemia in France.
    Ann Hematol. 2022;101:289-296.
    >> Share

  33. MARTINS SR, Toledo SLO, da Silva AJ, Mendes FS, et al
    Endothelial dysfunction biomarkers in sickle cell disease: is there a role for ADMA and PAI-1?
    Ann Hematol. 2022;101:273-280.
    >> Share

  34. DINGLI D, Matos JE, Lehrhaupt K, Krishnan S, et al
    The burden of illness in patients with paroxysmal nocturnal hemoglobinuria receiving treatment with the C5-inhibitors eculizumab or ravulizumab: results from a US patient survey.
    Ann Hematol. 2022;101:251-263.
    >> Share

  35. HOSOKAWA K, Nakao S
    Assay sensitivity of flow cytometric PNH analysis: response to Brando and Gatti.
    Ann Hematol. 2022;101:461-464.
    >> Share

  36. BRANDO B, Gatti A
    Re: Hosokawa K et al. Assay sensitivity of flow cytometric PNH analysis.
    Ann Hematol. 2022;101:459-460.
    >> Share

  37. DAS S, Karmakar K, Mukherjee R, Panda S, et al
    Acute stroke in young adult secondary to moyamoya angiopathy unveiling HbE-beta thalassemia.
    Ann Hematol. 2022;101:449-451.
    >> Share

    January 2022
  38. SUN YX, Feng Q, Wang SW, Li X, et al
    HLA-G-ILT2 interaction contributes to suppression of bone marrow B cell proliferation in acquired aplastic anemia.
    Ann Hematol. 2022 Jan 18. pii: 10.1007/s00277-022-04757.
    >> Share

  39. GHANEM P, Marrone K, Shanbhag S, Brahmer JR, et al
    Current challenges of hematologic complications due to immune checkpoint blockade: a comprehensive review.
    Ann Hematol. 2022;101:1-10.
    >> Share

  40. YILDIRIM N, Unal S, Yalcinkaya A, Karahan F, et al
    Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome.
    Ann Hematol. 2022;101:35-41.
    >> Share

  41. SOKOL J, Guman T, Chudej J, Hlebaskova M, et al
    Ixazomib, lenalidomide, and dexamethasone combination in "real-world" clinical practice in patients with relapsed/refractory multiple myeloma.
    Ann Hematol. 2022;101:81-89.
    >> Share

  42. ABULHAMAIL A, AlShebli A, Merdad L, Wali S, et al
    Prevalence of and risk factors for obstructive sleep apnea in children with sickle cell: a multicentric cross sectional study.
    Ann Hematol. 2022;101:43-57.
    >> Share

  43. TARTAGLIONE I, Manara R, di Concilio R, Quarta A, et al
    Non-transfusion-dependent thalassemia in Italy: less blues, no role of reds.
    Ann Hematol. 2022;101:241-242.
    >> Share

  44. MUSALLAM KM, Cappellini MD, Daar S, Taher AT, et al
    Morbidity-free survival and hemoglobin level in non-transfusion-dependent beta-thalassemia: a 10-year cohort study.
    Ann Hematol. 2022;101:203-204.
    >> Share

  45. ACQUAVIVA G, Nonne G, Murtas A, Longu F, et al
    Cytomegalovirus reactivation in patients under immunosuppressive treatment for autoimmune haemolytic anaemia.
    Ann Hematol. 2022;101:227-228.
    >> Share

  46. DEBUREAUX PE, Ruggiu M, Mathis S, Mirouse A, et al
    Aggressive lymphoma, hemophagocytic lymphohistiocytosis, and G6PD crisis: a lytic cocktail.
    Ann Hematol. 2022;101:219-221.
    >> Share

    December 2021
  47. EL-KHAZRAGY N, Matbouly S, Hanna DH, Mahran NA, et al
    Circulating miRNAs and tissue iron overload in transfusion-dependent beta-thalassemia major: novel predictors and follow-up guide.
    Ann Hematol. 2021;100:2909-2917.
    >> Share

  48. KARIMI M, Zarei T, Bahmanimehr A, Aramesh A, et al
    Long-term safety and efficacy of hydroxyurea in patients with non-transfusion-dependent beta-thalassemia: a comprehensive single-center experience.
    Ann Hematol. 2021;100:2901-2907.
    >> Share

    November 2021
  49. VIVES-CORRONS JL, Krishnevskaya E, Hernandez-Rodriguez I, Payan-Pernia S, et al
    Red cell ektacytometry in two patients with chronic hemolytic anemia and three new alpha-spectrin variants.
    Ann Hematol. 2021 Nov 29. pii: 10.1007/s00277-021-04723.
    >> Share

  50. JIANG Z, Jiang X, Chen M
    Severe aplastic anemia in a patient with erythropoietic protoporphyria successfully treated by avatrombopag.
    Ann Hematol. 2021 Nov 26. pii: 10.1007/s00277-021-04726.
    >> Share

  51. MATSUYAMA Y, Hosoi H, Horitani R, Kawamoto S, et al
    Management of warm autoimmune hemolytic anemia related to band 3-positive colon carcinoma.
    Ann Hematol. 2021 Nov 5. pii: 10.1007/s00277-021-04714.
    >> Share

  52. DUCA L, Nava I, Tavazzi D, Marcon A, et al
    Epidemiological shift of glucose-6-phosphate dehydrogenase mutations in northern Italy in the last 15 years.
    Ann Hematol. 2021;100:2683-2688.
    >> Share

  53. KULAGIN AD, Ptushkin VV, Lukina EA, Davydkin IL, et al
    Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab.
    Ann Hematol. 2021;100:2689-2698.
    >> Share

  54. TEAWTRAKUL N, Chansai S, Yamsri S, Ungarreevittaya P, et al
    JAK2V617F mutation in patients with beta-thalassemia disease: prevalence and clinical characteristics.
    Ann Hematol. 2021;100:2863-2865.
    >> Share

    October 2021
  55. EL FAKIH R, Alfraih F, Alhayli S, Ahmed SO, et al
    Frontline-matched sibling donor transplant of aplastic anemia patients using primed versus steady-state bone marrow grafts.
    Ann Hematol. 2021 Oct 31. pii: 10.1007/s00277-021-04708.
    >> Share

  56. BIASSI TP, Guerra-Shinohara EM, Moretti PNS, de Freitas Dutra V, et al
    miRNA profile and disease severity in patients with sickle cell anemia.
    Ann Hematol. 2021 Oct 22. pii: 10.1007/s00277-021-04665.
    >> Share

  57. PEREIRA-MARTINS DA, Coelho-Silva JL, Domingos IF, Weinhauser I, et al
    The ratio of ATP11C/PLSCR1 mRNA transcripts has clinical significance in sickle cell anemia.
    Ann Hematol. 2021 Oct 14. pii: 10.1007/s00277-021-04696.
    >> Share

  58. SHOKRGOZAR N, Karimi M, Golmoghaddam H, Rezaei N, et al
    Expression of the immune checkpoint receptors CTLA-4, LAG-3, and TIM-3 in beta-thalassemia major patients: correlation with alloantibody production and regulatory T cells (Tregs) phenotype.
    Ann Hematol. 2021;100:2463-2469.
    >> Share

  59. ABDULHAI F, Jaffa MA, Elias J, Zakka P, et al
    Digital thermography and vascular involvement in beta-thalassemia intermedia.
    Ann Hematol. 2021;100:2471-2477.
    >> Share

    September 2021
  60. HIRAMOTO N, Yamazaki H, Nakamura Y, Uchida N, et al
    Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation.
    Ann Hematol. 2021 Sep 21. pii: 10.1007/s00277-021-04664.
    >> Share

  61. THONG EWS, Tan SS, Sethi SK, Chee YL, et al
    Falsely elevated serum vitamin B12 levels in a case of pernicious anemia.
    Ann Hematol. 2021 Sep 10. pii: 10.1007/s00277-021-04612.
    >> Share

  62. WOUTERS HJCM, Conrads-Frank A, Koinig KA, Smith A, et al
    The anemia-independent impact of myelodysplastic syndromes on health-related quality of life.
    Ann Hematol. 2021 Sep 2. pii: 10.1007/s00277-021-04654.
    >> Share

  63. JANG T, Mo G, Stewart C, Khoury L, et al
    Obesity and diabetes mellitus in patients with sickle cell disease.
    Ann Hematol. 2021;100:2203-2205.
    >> Share

  64. BOGA C, Asma S, Leblebisatan G, Sen N, et al
    Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals.
    Ann Hematol. 2021;100:2195-2202.
    >> Share

    August 2021
  65. CHENOU F, Hounkpe BW, Domingos IF, Tonasse WV, et al
    Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients.
    Ann Hematol. 2021 Aug 28. pii: 10.1007/s00277-021-04636.
    >> Share

  66. YAMADA S, Kajikawa S, Nakagawa N, Kondo Y, et al
    Coombs' test positive autoimmune hemolytic anemia accompanied by myelodysplastic syndrome that became Coombs' test negative after azacitidine administration.
    Ann Hematol. 2021 Aug 27. pii: 10.1007/s00277-021-04652.
    >> Share

  67. ATIPIMONPAT A, Siwaponanan P, Khuhapinant A, Svasti S, et al
    Extracellular vesicles from thalassemia patients carry iron-containing ferritin and hemichrome that promote cardiac cell proliferation.
    Ann Hematol. 2021;100:1929-1946.
    >> Share

  68. TRANEKAER S, Hansen DL, Biemond BJ, Sorensen AL, et al
    Priapism in patients with hemolytic disorders: a nationwide retrospective cohort study.
    Ann Hematol. 2021;100:1947-1951.
    >> Share

  69. SINGHA K, Fucharoen G, Fucharoen S
    delta-Hemoglobinopathies in Thailand: screening, molecular basis, genotype-phenotype interaction, and implication for prevention and control of thalassemia.
    Ann Hematol. 2021;100:1953-1963.
    >> Share

  70. HOSOKAWA K, Ishiyama K, Ikemoto T, Sugimori C, et al
    The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with bone marrow failure.
    Ann Hematol. 2021;100:1975-1982.
    >> Share

  71. OKAMOTO H, Uoshima N, Kamitsuji Y, Kawata E, et al
    Paroxysmal nocturnal hemoglobinuria complicated with essential thrombocythemia harboring concomitant PIGA, CALR, and ASXL1 mutations.
    Ann Hematol. 2021;100:2113-2115.
    >> Share

  72. ROBIER C, Hoefler G, Aubell K, Hubmann E, et al
    Acquired elliptocytosis as presenting sign of a myelodysplastic syndrome associated with deletion of chromosome 20 and mutations in TET2, DNMT3A, and U2AF1.
    Ann Hematol. 2021;100:2111-2112.
    >> Share

  73. JAMWAL M, Mallik N, Aravindan AV, Jain A, et al
    Hemolytic erythrocytosis: an amalgamated phenotype from coinherited Chuvash polycythemia and G6PD Kerala-Kalyan with acquired transient stomatocytosis.
    Ann Hematol. 2021;100:2107-2109.
    >> Share

    July 2021
  74. NORASETTHADA L, Wongkhantee S, Chaipokam J, Charoenprasert K, et al
    Adult aplastic anemia in Thailand: incidence and treatment outcome from a prospective nationwide population-based study.
    Ann Hematol. 2021 Jul 16. pii: 10.1007/s00277-021-04566.
    >> Share

  75. YANG W, Zhao X, Peng G, Zhang L, et al
    Time and residual hematopoiesis are crucial for PNH clones escape in hepatitis-associated aplastic anemia.
    Ann Hematol. 2021 Jul 16. pii: 10.1007/s00277-021-04553.
    >> Share

  76. CAO J, Pei R, Zhang P, Liu X, et al
    Successful haploidentical transplantation using plasma exchange and post-transplantation cyclophosphamide for severe aplastic anemia patients with anti-human leukocyte antigen donor-specific antibodies.
    Ann Hematol. 2021 Jul 6. pii: 10.1007/s00277-021-04497.
    >> Share

  77. GOREN SAHIN D, Akay OM, Keklik M, Okan V, et al
    Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience.
    Ann Hematol. 2021;100:1667-1675.
    >> Share

  78. ELZAEEM DI, Sharkawi EAE, Zaki EM, Ghobrial AG, et al
    Comparative study of IgG binding to megakaryocytes in immune and myelodysplastic thrombocytopenic patients.
    Ann Hematol. 2021;100:1701-1709.
    >> Share

  79. NJUE L, Medri C, Keller P, Diepold M, et al
    The rare hemoglobin variant Hb Mizuho: report of a Swiss family and literature review.
    Ann Hematol. 2021;100:1677-1683.
    >> Share

  80. RICCHI P, Costantini S, Spasiano A, Cinque P, et al
    Hepatocellular carcinoma in patients with thalassemia in the post-DAA era: not a disappearing entity.
    Ann Hematol. 2021;100:1907-1910.
    >> Share

  81. MUSALLAM KM, Cappellini MD, Taher AT
    Variations in hemoglobin level and morbidity burden in non-transfusion-dependent beta-thalassemia.
    Ann Hematol. 2021;100:1903-1905.
    >> Share

  82. TRAN QUANG V, Tarfi S, Loustau V, Moutereau S, et al
    A belated diagnosis of G6PD deficiency in an 81-year-old woman.
    Ann Hematol. 2021;100:1901-1902.
    >> Share

    June 2021
  83. BATISTA JVGF, Pereira-Martins DA, Falcao DA, Domingos IF, et al
    Association of KLOTHO polymorphisms with clinical complications of sickle cell anemia.
    Ann Hematol. 2021 Jun 14. pii: 10.1007/s00277-021-04532.
    >> Share

  84. KRECAK I, Cengic M, Skoric I, Nakic M, et al
    Concomitant autoimmune hemolytic anemia and pure red cell aplasia in a patient with chronic lymphocytic leukemia successfully treated with ibrutinib.
    Ann Hematol. 2021 Jun 10. pii: 10.1007/s00277-021-04570.
    >> Share

  85. AL-TAWFIQ JA, Rabaan AA, AlEdreesi MH
    Frequency of bacteremia in patients with sickle cell disease: a longitudinal study.
    Ann Hematol. 2021;100:1411-1416.
    >> Share

  86. ARPACI A, Gul BU, Ozcan O, Ilhan G, et al
    Presentation of two new mutations in the 3'untranslated region of the beta-globin gene and evaluating the molecular spectrum of thalassemia mutations in the Mediterranean region of Turkey.
    Ann Hematol. 2021;100:1429-1438.
    >> Share

  87. BHURANI D, Kapoor J, Yadav N, Khushoo V, et al
    Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patients.
    Ann Hematol. 2021;100:1417-1427.
    >> Share

  88. MAROUF R, Adekile AD, El-Muzaini H, Abdulla R, et al
    Neutrophil gelatinase-associated lipocalin as a biomarker of nephropathy in sickle cell disease.
    Ann Hematol. 2021;100:1401-1409.
    >> Share

  89. TAMAI Y, Ito S, Hasegawa A
    Paroxysmal nocturnal haemoglobinuria associated with a novel phosphatidylinositol glycan class A (PIGA) mutation in a patient with Klinefelter syndrome.
    Ann Hematol. 2021;100:1625-1627.
    >> Share

    May 2021
  90. HERBRETEAU L, Le Calloch R, Arnaud B, Cassou N, et al
    Eculizumab, a real-life successful treatment for refractory cold agglutinin-mediated auto-immune hemolytic anemia secondary to lymphoproliferative disorders.
    Ann Hematol. 2021 May 18. pii: 10.1007/s00277-021-04557.
    >> Share

  91. QIN X, Zhu YP, Luo CJ, Zhou M, et al
    Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6-7/8 HLA-matched donor comparable to that from an 8/8 HLA-matched unrelated donor in severe aplastic anemia patients under 40 years.
    Ann Hematol. 2021 May 14. pii: 10.1007/s00277-021-04540.
    >> Share

  92. BALLAS SK
    Opioids are not a major cause of death of patients with sickle cell disease.
    Ann Hematol. 2021;100:1133-1138.
    >> Share

    April 2021
  93. MENDOZA E, Duque X, Moran S, Martinez-Andrade G, et al
    Hepcidin and other indicators of iron status, by alpha-1 acid glycoprotein levels, in a cohort of Mexican infants.
    Ann Hematol. 2021;100:879-890.
    >> Share

  94. RAMSAY Z, Gabbadon CH, Asnani M
    Numb chin syndrome in sickle cell disease: a case series of Jamaican patients.
    Ann Hematol. 2021;100:913-919.
    >> Share

  95. HATAIRAKTHAM S, Masaratana P, Hantaweepant C, Srisawat C, et al
    Curcuminoids supplementation ameliorates iron overload, oxidative stress, hypercoagulability, and inflammation in non-transfusion-dependent beta-thalassemia/Hb E patients.
    Ann Hematol. 2021;100:891-901.
    >> Share

    March 2021
  96. YOUSSEF JG, Zahiruddin F, Youssef G, Padmanabhan S, et al
    G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
    Ann Hematol. 2021;100:667-673.
    >> Share

  97. SAEIDNIA M, Nowrouzi-Sohrabi P, Erfani M, Fazeli P, et al
    The effect of curcumin on serum copper, zinc, and zinc/copper ratio in patients with beta-thalassemia intermedia: a randomized double-blind clinical trial.
    Ann Hematol. 2021;100:627-633.
    >> Share

  98. VERMA HK, Ratre YK, Bhaskar LVKS, Colombatti R, et al
    Erythrocyte microRNAs: a tiny magic bullet with great potential for sickle cell disease therapy.
    Ann Hematol. 2021;100:607-614.
    >> Share

  99. HAGHPANAH S, Cohan N, Bordbar M, Bazrafshan A, et al
    Effects of three months of treatment with vitamin E and N-acetyl cysteine on the oxidative balance in patients with transfusion-dependent beta-thalassemia.
    Ann Hematol. 2021;100:635-644.
    >> Share

  100. SCHULLER H, Klein F, Lubbert M, Prager EP, et al
    Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report.
    Ann Hematol. 2021;100:841-842.
    >> Share

  101. MISTRY RH, Kohut A, Ford P
    Correction of iron deficiency in hospitalized heart failure patients does not improve patient outcomes.
    Ann Hematol. 2021;100:661-666.
    >> Share

    February 2021
  102. HSIEH TC, Sostin O
    Severe warm autoimmune hemolytic anemia in COVID-19 managed with least incompatible RBC product and glucocorticoids.
    Ann Hematol. 2021 Feb 18. pii: 10.1007/s00277-021-04457.
    >> Share

  103. HATZLHOFER BLD, Pereira-Martins DA, de Farias Domingos I, Arcanjo GDS, et al
    Alpha thalassemia, but not beta(S)-globin haplotypes, influence sickle cell anemia clinical outcome in a large, single-center Brazilian cohort.
    Ann Hematol. 2021 Feb 13. pii: 10.1007/s00277-021-04450.
    >> Share

  104. LADEIRA VS, Barbosa AR, Oliveira MM, Ferreira LGR, et al
    ADAMTS-13-VWF axis in sickle cell disease patients.
    Ann Hematol. 2021;100:375-382.
    >> Share

  105. KUMAR R, Yadav R, Mishra S, Singh MPSS, et al
    Kruppel-like factor 1 (KLF1) gene single nucleotide polymorphisms in sickle cell disease and its association with disease-related morbidities.
    Ann Hematol. 2021;100:365-373.
    >> Share

  106. BATISTA JVGF, Arcanjo GS, Batista THC, Sobreira MJ, et al
    Influence of UGT1A1 promoter polymorphism, alpha-thalassemia and beta(s) haplotype in bilirubin levels and cholelithiasis in a large sickle cell anemia cohort.
    Ann Hematol. 2021 Feb 1. pii: 10.1007/s00277-021-04422.
    >> Share

    January 2021
  107. MARTYNOVA A, Chiu V, Mert M, Hermel D, et al
    Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series.
    Ann Hematol. 2021 Jan 9. pii: 10.1007/s00277-021-04401.
    >> Share

  108. STACY S, Sheth S, Coleman B, Cerenzia W, et al
    An assessment of the continuing medical education needs of US physicians in the management of patients with beta thalassemia.
    Ann Hematol. 2021;100:27-35.
    >> Share

    December 2020
  109. GIORDANO G, Napolitano M, Di Battista V, Lucchesi A, et al
    Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study.
    Ann Hematol. 2020 Dec 2. pii: 10.1007/s00277-020-04361.
    >> Share

  110. WU Y, Yao Q, Zhong M, Wu J, et al
    Genetic research and clinical analysis of deletional Chinese (G)gamma(+)((A)gammadeltabeta)(0) -thalassemia and Southeast Asian HPFH in South China.
    Ann Hematol. 2020;99:2747-2753.
    >> Share

  111. SINHA S, Jit BP, Patro ARK, Ray A, et al
    Influence of rs1042713 and rs1042714 polymorphisms of beta2-adrenergic receptor gene with erythrocyte cAMP in sickle cell disease patients from Odisha State, India.
    Ann Hematol. 2020;99:2737-2745.
    >> Share

  112. PAZGAL I, Yahalom V, Shalev B, Raanani P, et al
    Alloimmunization and autoimmunization in adult transfusion-dependent thalassemia patients: a report from a comprehensive center in Israel.
    Ann Hematol. 2020;99:2731-2736.
    >> Share

    November 2020
  113. MENDEZ M, Moreno-Carralero MI, Peri VL, Camacho-Galan R, et al
    Congenital dyserythropoietic anemia types Ib, II, and III: novel variants in the CDIN1 gene and functional study of a novel variant in the KIF23 gene.
    Ann Hematol. 2020 Nov 7. pii: 10.1007/s00277-020-04319.
    >> Share

  114. RUAN J, Zuo W, Chen M, Yang C, et al
    Correction to: Eltrombopag is effective in patients with relapse/refractory aplastic anemia-report from a single center in China.
    Ann Hematol. 2020 Nov 2. pii: 10.1007/s00277-020-04301.
    >> Share

  115. ABDULLAH N, Ismail N, Abd Jalal N, Mohd Radin F, et al
    Prevalence of anaemia and associated risk factors amongst The Malaysian Cohort participants.
    Ann Hematol. 2020;99:2521-2527.
    >> Share

  116. DESAI RJ, Mahesri M, Globe D, Mutebi A, et al
    Clinical outcomes and healthcare utilization in patients with sickle cell disease: a nationwide cohort study of Medicaid beneficiaries.
    Ann Hematol. 2020;99:2497-2505.
    >> Share

  117. BALLAS SK, Dampier C
    Risk factors associated with increased emergency department utilization in patients with sickle cell disease: a systematic literature review.
    Ann Hematol. 2020;99:2483-2495.
    >> Share

  118. KIRITO K
    Expansion of paroxysmal nocturnal hemoglobinuria clones in MPLW515L mutation harboring primary myelofibrosis.
    Ann Hematol. 2020;99:2707-2709.
    >> Share

  119. TRIPATHI P, Agarwal S, Gupta A, Mandal K, et al
    Biallelic rare 17 bp deletion mutation (HBB:c.380_396 del TGCAGGCTGCCTATCAG) in a transfusion depended form of thalassemia.
    Ann Hematol. 2020;99:2719-2722.
    >> Share

    October 2020
  120. WAN K, Yin Y, Luo Z, Cheng J, et al
    Correction to: Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia.
    Ann Hematol. 2020 Oct 16. pii: 10.1007/s00277-020-04300.
    >> Share

  121. ONISHI Y, Mori T, Yamazaki H, Takenaka K, et al
    Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemia.
    Ann Hematol. 2020 Oct 9. pii: 10.1007/s00277-020-04290.
    >> Share

  122. LAN Y, Chang L, Yi M, Cai Y, et al
    Long-term outcomes of 172 children with severe aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine.
    Ann Hematol. 2020 Oct 8. pii: 10.1007/s00277-020-04296.
    >> Share

  123. ONISHI Y, Yokoyama H, Katsuoka Y, Ito T, et al
    Low-dose lenalidomide and dexamethasone therapy after melphalan-prednisolone induction in elderly patients with newly diagnosed multiple myeloma.
    Ann Hematol. 2020;99:2351-2356.
    >> Share

  124. FUREDER W, Sperr WR, Heibl S, Zebisch A, et al
    Prognostic factors and follow-up parameters in patients with paroxysmal nocturnal hemoglobinuria (PNH): experience of the Austrian PNH network.
    Ann Hematol. 2020;99:2303-2313.
    >> Share

  125. BUTTARI B, Profumo E, Caprari P, Massimi S, et al
    Phenotypical and functional abnormalities of circulating neutrophils in patients with beta-thalassemia.
    Ann Hematol. 2020;99:2265-2277.
    >> Share

  126. EL-GHAMRAWY M, Yassa ME, Tousson AMS, El-Hady MA, et al
    Association between BCL11A, HSB1L-MYB, and XmnI gammaG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
    Ann Hematol. 2020;99:2279-2288.
    >> Share

  127. CHUANG TY, Li JP, Weng TF, Wu KH, et al
    Combined chelation with high-dose deferiprone and deferoxamine to improve survival and restore cardiac function effectively in patients with transfusion-dependent thalassemia presenting severe cardiac complications.
    Ann Hematol. 2020;99:2289-2294.
    >> Share

  128. FRIEDRICH C, Gay J, Alary AS, Arlet JB, et al
    Battle of the clones: paroxysmal nocturnal hemoglobinuria vs myelodysplastic syndrome.
    Ann Hematol. 2020;99:2459-2461.
    >> Share

    September 2020
  129. DREXLER B, Zurbriggen F, Diesch T, Viollier R, et al
    Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation.
    Ann Hematol. 2020 Sep 19. pii: 10.1007/s00277-020-04271.
    >> Share

  130. WAN K, Yin Y, Luo Z, Cheng J, et al
    Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia.
    Ann Hematol. 2020 Sep 17. pii: 10.1007/s00277-020-04269.
    >> Share

  131. RUAN J, Zuo W, Chen M, Yang C, et al
    Eltrombopag is effective in patients with relapse/refractory aplastic anemia-report from a single center in China.
    Ann Hematol. 2020 Sep 17. pii: 10.1007/s00277-020-04266.
    >> Share

  132. ASLEH M, Levitas A, Daniel S, Abu-Quider A, et al
    Hepatic and cardiac iron load as determined by MRI T2* in patients with congenital dyserythropoietic anemia type I.
    Ann Hematol. 2020 Sep 12. pii: 10.1007/s00277-020-04263.
    >> Share

  133. ALGASSIM AA, Elghazaly AA, Alnahdi AS, Mohammed-Rahim OM, et al
    Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection.
    Ann Hematol. 2020 Sep 12. pii: 10.1007/s00277-020-04256.
    >> Share

  134. GIANESIN B, Pinto VM, Casale M, Corti P, et al
    Manual erythroexchange in sickle cell disease: multicenter validation of a protocol predictive of volume to exchange and hemoglobin values.
    Ann Hematol. 2020;99:2047-2055.
    >> Share

  135. SHRESTHA O, Khadwal AR, Singhal M, Trehan A, et al
    A high frequency of Gilbert syndrome (UGT1A1*28/*28) and associated hyperbilirubinemia but not cholelithiasis in adolescent and adult north Indian patients with transfusion-dependent beta-thalassemia.
    Ann Hematol. 2020;99:2019-2026.
    >> Share

  136. SALIBA AN, Atoui A, Labban M, Hamade H, et al
    Thalassemia in the emergency department: special considerations for a rare disease.
    Ann Hematol. 2020;99:1967-1977.
    >> Share

  137. BORTOLOTTI M, D'Ambrosio R, Fraquelli M, Pedrotti P, et al
    Liver damage and sickle cell disease: genotype relationship.
    Ann Hematol. 2020;99:2065-2072.
    >> Share

  138. NUALKAEW T, Khamphikham P, Pongpaksupasin P, Kaewsakulthong W, et al
    UNC0638 induces high levels of fetal hemoglobin expression in beta-thalassemia/HbE erythroid progenitor cells.
    Ann Hematol. 2020;99:2027-2036.
    >> Share

  139. DAAR S, Al Khabori M, Al Rahbi S, Hassan M, et al
    Cardiac T2* MR in patients with thalassemia major: a 10-year long-term follow-up.
    Ann Hematol. 2020;99:2009-2017.
    >> Share

  140. RHODES A, Martin S, Wolters P, Rodriguez Y, et al
    Sleep disturbance in adults with sickle cell disease: relationships with executive and psychological functioning.
    Ann Hematol. 2020;99:2057-2064.
    >> Share

  141. DIMITROGLOU Y, Anagnostopoulos F, Aggeli C, Delicou S, et al
    Severity of heart failure and health-related quality of life in beta-thalassemia patients: a cross-sectional study.
    Ann Hematol. 2020;99:2037-2046.
    >> Share

  142. DESAI R, Bansod S, Patel U
    Nationwide prevalence and trends in acute cardiovascular events and in-hospital mortality among adult African Americans with sickle cell trait.
    Ann Hematol. 2020;99:2207-2209.
    >> Share

  143. ANTWI-BOASIAKO C, Andemariam B, Colombatti R, Asare EV, et al
    A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis.
    Ann Hematol. 2020;99:2073-2079.
    >> Share

    August 2020
  144. LONG Z, Li H, Du Y, Chen M, et al
    Gene mutation profile in patients with acquired pure red cell aplasia.
    Ann Hematol. 2020;99:1749-1754.
    >> Share

  145. HUSCENOT T, Galland J, Ouvrat M, Rossignol M, et al
    SARS-CoV-2-associated cold agglutinin disease: a report of two cases.
    Ann Hematol. 2020;99:1943-1944.
    >> Share

  146. LI L, Li Y, Lin L, Yin J, et al
    Outcomes of allogeneic haematopoietic stem cell transplantation for patients with severe aplastic anaemia using the porcine antilymphocyte globulin-containing conditioning regimen.
    Ann Hematol. 2020;99:1863-1871.
    >> Share

  147. LANCMAN G, Marcellino BK, Thibaud S, Troy K, et al
    Coombs-negative hemolytic anemia and elevated plasma hemoglobin levels in COVID-19.
    Ann Hematol. 2020 Aug 1. pii: 10.1007/s00277-020-04202.
    >> Share

    July 2020
  148. SERVATYARI K, Moradveisi B, Yazdanpanah H, Bacigalupo A, et al
    A 30-month-old boy with aplastic anemia caused by electrocution.
    Ann Hematol. 2020 Jul 24. pii: 10.1007/s00277-020-04189.
    >> Share

  149. BETTELLI F, Giusti D, Morselli M, Colaci E, et al
    Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study.
    Ann Hematol. 2020 Jul 23. pii: 10.1007/s00277-020-04191.
    >> Share

  150. KANG KW, Moon H, Lee BH, Jeon MJ, et al
    Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab.
    Ann Hematol. 2020;99:1493-1503.
    >> Share

  151. HARIHARAN P, Kishnani P, Sawant P, Gorivale M, et al
    Genotypic-phenotypic heterogeneity of deltabeta-thalassemia and hereditary persistence of fetal hemoglobin (HPFH) in India.
    Ann Hematol. 2020;99:1475-1483.
    >> Share

  152. CHEN Z, Chen M, Yang C, Han B, et al
    Immunosuppression therapy is effective for both acquired tumor-associated and primary pure red cell aplasia: a match pair case-control study.
    Ann Hematol. 2020;99:1485-1491.
    >> Share

  153. GARCIA-MORIN M, Bardon-Cancho EJ, Belendez C, Zamarro R, et al
    Fifteen years of newborn sickle cell disease screening in Madrid, Spain: an emerging disease in a European country.
    Ann Hematol. 2020;99:1465-1474.
    >> Share

  154. SCHREZENMEIER H, Roth A, Araten DJ, Kanakura Y, et al
    Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry.
    Ann Hematol. 2020;99:1505-1514.
    >> Share

    June 2020
  155. HUO J, Li X, Shao Y, Ren X, et al
    Long-term follow-up of a novel immunosuppressive strategy of cyclosporine alternatively combined with levamisole for severe aplastic anemia.
    Ann Hematol. 2020 Jun 29. pii: 10.1007/s00277-020-04153.
    >> Share

  156. AMES PRJ, Jeffrey S
    Bortezomib and rituximab in multiply relapsed primary warm autoimmune hemolytic anemia.
    Ann Hematol. 2020 Jun 17. pii: 10.1007/s00277-020-04135.
    >> Share

  157. HOCHMAN MJ, Martin DB
    Coincidence of autoimmune hemolytic anemia and pure red cell aplasia in a patient with CLL.
    Ann Hematol. 2020 Jun 16. pii: 10.1007/s00277-020-04091.
    >> Share

  158. CAPES A, Bailly S, Hantson P, Gerard L, et al
    COVID-19 infection associated with autoimmune hemolytic anemia.
    Ann Hematol. 2020 Jun 16. pii: 10.1007/s00277-020-04137.
    >> Share

  159. KRECAK I, Supe M, Ilic I, Gveric-Krecak V, et al
    Behet-like syndrome associated with aplastic anemia successfully treated with mycophenolate mofetil.
    Ann Hematol. 2020 Jun 13. pii: 10.1007/s00277-020-04119.
    >> Share

  160. GAUT D, Jones J, Chen C, Ghafouri S, et al
    Outcomes related to intravenous fluid administration in sickle cell patients during vaso-occlusive crisis.
    Ann Hematol. 2020;99:1217-1223.
    >> Share

  161. RICCHI P, Meloni A, Costantini S, Spasiano A, et al
    Red blood cell consumption in a large cohort of patients with thalassaemia: a retrospective analysis of main predictors.
    Ann Hematol. 2020;99:1209-1215.
    >> Share

    May 2020
  162. SALES RR, Belisario AR, Faria G, Mendes F, et al
    Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
    Ann Hematol. 2020 May 23. pii: 10.1007/s00277-020-04079.
    >> Share

  163. XU M, Zhao X, Sun F, Zhu R, et al
    A case of iron deficiency anemia with extremely hyperferritinemia responds well to oral iron: the first identified hereditary hyperferritinemia cataract syndrome in China.
    Ann Hematol. 2020 May 20. pii: 10.1007/s00277-020-04085.
    >> Share

  164. JAIN A, Gupta DK
    Daratumumab for refractory warm autoimmune hemolytic anemia.
    Ann Hematol. 2020 May 14. pii: 10.1007/s00277-020-04063.
    >> Share

  165. ALVES AC, da Silva VAL, Dos Santos A, Serra MB, et al
    Sickle cell anemia in the state of Maranhao: a haplotype study.
    Ann Hematol. 2020 May 4. pii: 10.1007/s00277-020-04048.
    >> Share

  166. SVIDNICKI MCCM, Zanetta GK, Congrains-Castillo A, Costa FF, et al
    Targeted next-generation sequencing identified novel mutations associated with hereditary anemias in Brazil.
    Ann Hematol. 2020;99:955-962.
    >> Share

  167. SHAH F, Dwivedi M
    Pathophysiology and recent therapeutic insights of sickle cell disease.
    Ann Hematol. 2020;99:925-935.
    >> Share

    April 2020
  168. MIHAILESCU AM, Musallam KM, Cappellini MD, Taher AT, et al
    Less 'reds' more 'blues': hemoglobin level and depression in non-transfusion-dependent thalassemia.
    Ann Hematol. 2020;99:903-904.
    >> Share

  169. MORE TA, Dongerdiye R, Devendra R, Warang PP, et al
    Mechanosensitive Piezo1 ion channel protein (PIEZO1 gene): update and extended mutation analysis of hereditary xerocytosis in India.
    Ann Hematol. 2020;99:715-727.
    >> Share

  170. AZMAN NF, Abdullah WZ, Hanafi S, Diana R, et al
    Genetic polymorphisms of HbE/beta thalassemia related to clinical presentation: implications for clinical diversity.
    Ann Hematol. 2020;99:729-735.
    >> Share

  171. BEWERSDORF JP, Zeidan AM
    Evolving therapies for lower-risk myelodysplastic syndromes.
    Ann Hematol. 2020;99:677-692.
    >> Share

  172. CHEN Z, Liu X, Chen M, Yang C, et al
    Successful sirolimus treatment of patients with pure red cell aplasia complicated with renal insufficiency.
    Ann Hematol. 2020;99:737-741.
    >> Share

    March 2020
  173. JAMWAL M, Aggarwal A, Sharma P, Bansal D, et al
    Congenital dyserythropoietic anemia type IV with high fetal hemoglobin caused by heterozygous KLF1 p.Glu325Lys: first report in an Indian infant.
    Ann Hematol. 2020 Mar 27. pii: 10.1007/s00277-020-03982.
    >> Share

  174. RENO CO, Barbosa AR, de Carvalho SS, Pinheiro MB, et al
    Oxidative stress assessment in sickle cell anemia patients treated with hydroxyurea.
    Ann Hematol. 2020 Mar 12. pii: 10.1007/s00277-020-03987.
    >> Share

  175. CHEN M, Zhuang J, Yang C, Zhang L, et al
    Rapid response to a single-dose rituximab combined with bortezomib in refractory and relapsed warm autoimmune hemolytic anemia.
    Ann Hematol. 2020 Mar 7. pii: 10.1007/s00277-020-03976.
    >> Share

  176. DOMINGOS IF, Pereira-Martins DA, Sobreira MJVC, Oliveira RTD, et al
    High levels of proinflammatory cytokines IL-6 and IL-8 are associated with a poor clinical outcome in sickle cell anemia.
    Ann Hematol. 2020 Mar 5. pii: 10.1007/s00277-020-03978.
    >> Share

  177. DE LUNA G, Darnige L, Roueff S, Peyrard T, et al
    Usefulness of azacitidine therapy in a sickle cell disease patient with myelodysplastic syndrome.
    Ann Hematol. 2020;99:661-662.
    >> Share

  178. SHOKRGOZAR N, Amirian N, Ranjbaran R, Bazrafshan A, et al
    Evaluation of regulatory T cells frequency and FoxP3/GDF-15 gene expression in beta-thalassemia major patients with and without alloantibody; correlation with serum ferritin and folate levels.
    Ann Hematol. 2020;99:421-429.
    >> Share

  179. LIU X, Lu X, Chen L, Yang Y, et al
    Immunosuppressive therapy for elderly-acquired pure red cell aplasia: cyclosporine A may be more effective.
    Ann Hematol. 2020;99:443-449.
    >> Share

    February 2020
  180. PEFFAULT DE LATOUR R, Huynh L, Ivanova JI, Totev T, et al
    Burden of illness among patients with severe aplastic anemia who have had insufficient response to immunosuppressive therapy: a multicenter retrospective chart review study.
    Ann Hematol. 2020 Feb 17. pii: 10.1007/s00277-019-03809.
    >> Share

  181. NICOLETTI E, Rao G, Bueren JA, Rio P, et al
    Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization.
    Ann Hematol. 2020 Feb 17. pii: 10.1007/s00277-020-03954.
    >> Share

    January 2020
  182. RUSSO G, Guardabasso V, Romano F, Corti P, et al
    Monitoring oral iron therapy in children with iron deficiency anemia: an observational, prospective, multicenter study of AIEOP patients (Associazione Italiana Emato-Oncologia Pediatrica).
    Ann Hematol. 2020 Jan 21. pii: 10.1007/s00277-020-03906.
    >> Share

  183. EL-GAMAL RAE, Abdel-Messih IY, Habashy DM, Zaiema SEG, et al
    Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia.
    Ann Hematol. 2020;99:31-39.
    >> Share

    December 2019
  184. QIU Y, Cai H, Cui L, Liu YX, et al
    Identification of a novel heterozygous ALAS2 mutation in a young Chinese female with X-linked sideroblastic anemia.
    Ann Hematol. 2019 Dec 17. pii: 10.1007/s00277-019-03894.
    >> Share

  185. KAUNDAL R, Bhatia P, Jain A, Jain A, et al
    Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia.
    Ann Hematol. 2019 Dec 6. pii: 10.1007/s00277-019-03871.
    >> Share

  186. PARK S, Kelaidi C, Meunier M, Casadevall N, et al
    Correction to: The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion.
    Ann Hematol. 2019 Dec 2. pii: 10.1007/s00277-019-03874.
    >> Share

  187. LAURENTINO MR, Parente Filho SLA, Parente LLC, da Silva Junior GB, et al
    Non-invasive urinary biomarkers of renal function in sickle cell disease: an overview.
    Ann Hematol. 2019;98:2653-2660.
    >> Share

  188. YINGJUN X, Yuhuan X, Yuchang C, Dongzhi L, et al
    CRISPR/Cas9 gene correction of HbH-CS thalassemia-induced pluripotent stem cells.
    Ann Hematol. 2019;98:2661-2671.
    >> Share

    November 2019
  189. LV X, Dong S, Lan F, Zhang B, et al
    Congenital dyserythropoietic anemia type I mimicking myelodysplasia syndrome with a novel CDAN1 mutation.
    Ann Hematol. 2019 Nov 23. pii: 10.1007/s00277-019-03848.
    >> Share

  190. SABUNCUOGLU S, Oztas Y, Yalcinkaya A, Unal S, et al
    The increased neopterin content in turkish pediatric patients with sickle cell anemia.
    Ann Hematol. 2019 Nov 23. pii: 10.1007/s00277-019-03817.
    >> Share

  191. OLATUNYA OS, Lanaro C, Longhini AL, Penteado CFF, et al
    Red blood cells microparticles are associated with hemolysis markers and may contribute to clinical events among sickle cell disease patients.
    Ann Hematol. 2019;98:2507-2521.
    >> Share

  192. MASY V, Sokal E, Ranguelov N, Brichard B, et al
    Fatal type B lactic acidosis in a patient with end-stage liver disease related to homozygous sickle cell disease.
    Ann Hematol. 2019;98:2627-2628.
    >> Share

    October 2019
  193. CHOQUE-QUISPE BM, Paz V, Gonzales GF
    Proportion of anemia attributable to iron deficiency in high-altitude infant populations.
    Ann Hematol. 2019 Oct 30. pii: 10.1007/s00277-019-03823.
    >> Share

  194. PARK S, Kelaidi C, Meunier M, Casadevall N, et al
    The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion.
    Ann Hematol. 2019 Oct 25. pii: 10.1007/s00277-019-03799.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016